CQ Pharmaceutical Holding Co (SZSE:000950) ROC %: 1.22% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000950 CQ Pharmaceutical Holding Co Ltd SZSE:000950
77 GF Score
Price ¥5.17
GF Value ¥5.68
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is CQ Pharmaceutical Holding Co ROC %?

CQ Pharmaceutical Holding Co SZSE:000950 77 ROC % is 1.22% as of Jun. 2026. GuruFocus rates SZSE:000950 with a GF Score™ of 77/100 and a GF Value™ of ¥5.68 (Fairly Valued). The stock has 8 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. CQ Pharmaceutical Holding Co's annualized return on capital (ROC %) for the quarter that ended in Jun. 2026 was 1.22%.

As of today (2026-09-16), CQ Pharmaceutical Holding Co's WACC % is 4.36%. CQ Pharmaceutical Holding Co's ROC % is 3.30% (calculated using TTM income statement data). CQ Pharmaceutical Holding Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


CQ Pharmaceutical Holding Co  (SZSE:000950) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, CQ Pharmaceutical Holding Co's WACC % is 4.36%. CQ Pharmaceutical Holding Co's ROC % is 3.30% (calculated using TTM income statement data). CQ Pharmaceutical Holding Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


CQ Pharmaceutical Holding Co ROC % Related Terms


CQ Pharmaceutical Holding Co ROC % Historical Data

* Premium members only.

The historical data trend for CQ Pharmaceutical Holding Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CQ Pharmaceutical Holding Co ROC % Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.34 4.46 3.13 0.00 0.51

CQ Pharmaceutical Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 1.56 -0.82 1.71 1.22
SZSE:000950
77GF Score
CQ Pharmaceutical Holding Co Ltd SZSE:000950
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CQ Pharmaceutical Holding Co ROC % Calculation

CQ Pharmaceutical Holding Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=1002.08604421 * ( 1 - 78.213% )/( (43027.1604615 + 43171.76283078)/ 2 )
=218.32448645203/43099.46164614
=0.51 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=66630.3297421 - 14211.66109551 - ( 9391.50818509 - max(0, 44063.87099717 - 57419.91173287+9391.50818509))
=43027.1604615

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=66317.78913093 - 16462.03437536 - ( 6683.99192479 - max(0, 46740.73568296 - 56951.6007966+6683.99192479))
=43171.76283078

CQ Pharmaceutical Holding Co's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=1116.96717708 * ( 1 - 48.061% )/( (47569.42611939 + 47260.28841042)/ 2 )
=580.14158210358/47414.857264905
=1.22 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=68795.2301809 - 16333.37914524 - ( 4892.42491627 - max(0, 49601.07780608 - 59316.65168669+4892.42491627))
=47569.42611939

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=68075.01160655 - 15994.34687468 - ( 4820.37632145 - max(0, 49481.39176741 - 58690.89643979+4820.37632145))
=47260.28841042

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 1.22% mean?
CQ Pharmaceutical Holding Co (SZSE:000950) has a ROC % of 1.22% as of Jun. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on CQ Pharmaceutical Holding Co and its competitors.
Is CQ Pharmaceutical Holding Co's ROC % too high?
CQ Pharmaceutical Holding Co's current ROC % is 1.22%. The Medical Distribution industry median ROC % is 5.29. CQ Pharmaceutical Holding Co's value of 1.22% is 76.9% below this industry median. Overall, CQ Pharmaceutical Holding Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CQ Pharmaceutical Holding Co's ROC % compare to MCK and COR?
CQ Pharmaceutical Holding Co's ROC % of 1.22% can be compared against companies in the Medical Distribution industry. The industry median ROC % is 5.29. CQ Pharmaceutical Holding Co's value of 1.22% is 76.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Distribution company?
The median ROC % among Medical Distribution companies is 5.29, based on 123 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CQ Pharmaceutical Holding Co's current ROC % of 1.22% is 76.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on CQ Pharmaceutical Holding Co and its competitors. For the Medical Distribution industry, the median ROC % is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CQ Pharmaceutical Holding Co's current ROC % is 1.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CQ Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co (SZSE:000950) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.68, compared to a current price of ¥5.17 — trading 9% below its estimated fair value. The current ROC % is 1.22% and 76.9% below the Medical Distribution industry median of 5.29. CQ Pharmaceutical Holding Co's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For CQ Pharmaceutical Holding Co (SZSE:000950), the current ROC % is 1.22% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?

Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued. The current stock price of ¥5.17 is trading 9% below its estimated GF Value™ of ¥5.68. GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.

Key valuation signals for SZSE:000950:

  • ROC %: 1.22%
  • GF Value™: ¥5.68 vs. price of ¥5.17 (9% below fair value)
  • GF Score™: 77/100 with 8 warning signs
  • Industry Position: 76.9% below the Medical Distribution median

No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CQ Pharmaceutical Holding Co Business Description

Address 333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
77GF Score

Get the complete analysis for SZSE:000950

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.17
Price
¥5.68
GF Value